UT Southwestern Targets New Protein for Safer Cancer Treatment
UT Southwestern researchers have discovered that a little-known protein, midnolin, helps cancerous B cells survive in blood cancers like leukemia and lymphoma. By mapping its structure, scientists found a way to potentially target and disable midnolin—killing up to 92% of cancer cells in lab models while sparing healthy ones. The breakthrough could lead to more precise cancer therapies with fewer side effects.
UT Southwestern Targets New Protein for Safer Cancer Treatment